High basal level gene expression of thymidine phosphorylase (platelet- derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2371-2376

  Metzger, Ralf ^a   Danenberg, Kathleen ^a   Leichman, C Gail ^a   Salonga, Dennis ^a   Schwartz, Edward L ^b   Wadler, Scott ^b   Lenz, Heinz Josef ^a   Groshen, Susan ^a   Leichman, Lawrence ^a   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; FLUOROURACIL; IRINOTECAN; LEVULINIC ACID; MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL DEATH; CLINICAL ARTICLE; COLORECTAL CANCER; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FLUOROURACIL; HUMANS; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

EID: 0031722179     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Friedkin, D., and Roberts, D. The enzymatic synthesis of nucleosides. J. Biol. Chem., 207: 245-256, 1954.
2. Iltzsch, M. H., el Kouni, M. H., and Cha, S. Kinetic studies of thymidine phosphorylase. Biochemistry, 24: 6799-6807, 1985.
3. Zimmerman, M., and Seidenberg, J. Deoxyribosyl transfer. I. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J. Biol. Chem., 230: 2618-2621, 1964.
4. O'Brien, T. S., Fox, S. B., Dickinson, A. J., Turley, H., Westwood, M., Moghaddam, A., Gatter, K. C., Bicknell, R., and Harris, A. L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res., 56: 4799-4804, 1996.
5. Barton, G. J., Ponting, C. P., Spraggon, C., Finnis, C., and Sleep, D. Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. Prot. Sci., 1: 688-690, 1992.
6. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., and Akiyama, S. I. Angiogenic factor. Nature (Lond), 356: 668, 1992.
7. Moghaddam, M. H., and Bicknell, R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry, 31: 12141-12146, 1992.
8. Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason, A., and Heldin, C. H. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem. Biophys. Res. Commun., 184: 1311-1316, 1992.
9. Finnis, C., Dodsworth, N., Pollit, C. E., Carr, G., and Sleep, D. Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur. J. Biochem., 212: 201-210, 1993.
10. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1988.
11. Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., and Akiyama, S-I. Angiogenic activity of enzymes. Nature (Lond.), 356: 198, 1994.
12. Moghaddam, A. Zhang, H-T., Fan, T-P., Hu, D-E., Lees, V., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA. 92: 988-1002, 1995.
13. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer, 64: 79-82, 1995.
14. Takahashi, Y., Bucana, C. D., Liu, W., Yoneda, J., Clearly, K. R., and Ellis, L. M. Platelet-derived endothelial cell growth factor in human colon carcinogenesis: role of infiltrating cells. J. Natl. Cancer Inst., 88: 1146-1151, 1996.
15. Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F, and Aikou, T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst., 88: 1110-1117, 1996.
16. Takebayashi, Y., Miyadera, K., Akiyama, S., Hokita, S., Yamada, K., Akiba, S., Yamada, Y., Sumizawa, T., and Aikou, T. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res., 87: 288-295, 2996.
17. Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y., and Sowa, M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br. J. Cancer, 73: 884-888, 1996.
18. Imazano, Y., Takebayashi, Y., Nishiyama, K., Akiba, S., Miyadera, K., Yamada, Y., Akiyama, S., and Ohi, Y. Correlation between thymidine phosphorylase and prognosis in human renal cell carcinoma. J. Clin. Oncol., 15: 257-2578, 1997.
19. Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S., Bourne, T. H., Lawton, F., Moghaddam, A., Harris, A. L., and Bicknell, R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst., 86: 1234-1238, 1994.
20. Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., and Akiyama, S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res., 55: 1687-1690, 1995.
21. Birnie, G. D., Kroeger, H., and Heidelberger, C. Studies of fluorinated pyrimidines. XVIII. The degradation of 5-fluoro-2′-deoxyuridine and related compounds by nucleoside phosphorylase. Biochemistry, 2: 566-572, 1963.
22. Baker, B. R., and Kelley, J. L. Irreversible enzyme inhibitors. CLXXI. Inhibition of FUDR phosphorylase from Walker 256 rat tumor by 6-substituted uracils. J. Med. Chem., 13: 461-467, 1970.
23. Santelli, G., and Birnie, F. In vivo potentiation of 5-fluorouracil toxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides. J. Natl. Cancer Inst., 64: 69-72, 1980.
24. Evans, R. M., Laskin, J. D., and Hakala, M. T. Effect of folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res., 29: 807-811, 1981.
25. Schwartz, E. L., Baptiste, N., Wadler, S., and Makower, D. Thymidine phosphorylase mediates the sensitivity of colon carcinoma cells to 5-fluorouracil. J. Biol. Chem., 270: 19073-19077, 1995.
26. Kato, Y., Matsukawa, S., Muraoka, R., and Tanigawa, N. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. Br. J. Cancer. 75: 506-511, 1997.
27. Schwartz, E. L., Hoffman, M., O'Connor, C. J., and Wadler, S. Stimulation of 5-fluorouracil metabolic activation by interferon-A in human colon carcinoma cells. Biochem. Biophys. Res. Commun., 182: 1232-1239, 1992.
28. Elias, S., and Sandoval, J. M. Interferon effects upon fluorouracil metabolism by HL-60 cells. Biophys. Biochem. Res. Commun., 163: 867-874, 1989.
29. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K., and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol., 32: 333-338, 1993.
30. Luccioni, C., Beaumatin, J., Bardot, V., and Lefrancois, D. Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int. J. Cancer, 58: 517-522, 1994.
31. Folkman, J. What is the role of thymidine phosphorylase in tumor angiogenesis? J. Natl. Cancer Inst., 88: 1091-1092, 1996.
32. Leichman, C. G., Lenz, H-J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusion 5-fluorouracil and weekly leucovorin. J. Clin. Oncol., 75: 3223-3229, 1997.
33. Leichman, C. G., Leichman, L., Spears, C. P., Rosen, P. J., Jeffers, S., and Groshen, S. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated gastrointestinal cancers. J. Natl. Cancer Inst., 85: 41-44, 1993.
34. Green, S., and Weiss, G. R., Southwest Oncology Group standard response criteria, endpoint definitions, and toxicity criteria. Invest. New Drugs, 10: 239-253, 1992.
35. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. L. C., Aigner, K., Gustavsson, B., Leichman, L., Frösing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
36. Lenz, H-J., Hill, C., Danenberg, K. D., Leichman, L. L., Priest, D. G., and Danenberg, P. V. Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. PCR Methods Appl., 4: 305-309, 1995.
37. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
38. Kuo D. Y-S., Mallick, S., Shen, H-J., DeVictoria, C., Jones, J., Fields, A. L., Goldberg, G. L., Runowicz, C. D., and Horwitz, S. B. Clin. Cancer Res., 2: 1981-1992, 1996.
39. Graf, W., Pählman, L., Bergström, R., and Glimelius, B. The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br. J. Cancer. 70: 559-563, 1994.
40. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA, 88: 8977-8981, 1991.
41. Schwartz, E. L., Baptiste, N., Megati, S., Wadler, S., and Otter, B. A. 5-Ethoxy-2′-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. Cancer Res., 55: 3543-3550, 1995.
42. Lu, C., and Tanigawa, N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res., 57: 221-224, 1997.
43. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
44. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
45. Takebayashi, Y., Yamada, K., Miyadera, K., Sumizawa, T., Furukawa, T., Kinoshita, F., Aoki, D., Okumura H., Yamada, Y., Akiyama, S., and Aikou, T. The activity and expression of thymidine phosphorylase in human solid tumors. Eur. J. Cancer, 32A: 1227-1232, 1996.
46. Luccioni, C., Beaumatin, J., Bardot, V., and Lefrancois, D. Pyrimidine nucleoside metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int. J. Cancer, 58: 517-522, 1994.